APA (7th ed.) Citation

Rabab Mahmoud Ahmed, Nehal Kamal Rakha, Ahmed Yousry, & Amin Roshdy Soliman. (2024). Potential impact of sodium glucose co-transporter (SGLT2) inhibitors on cholesterol fractions in stage 3 chronic kidney disease. SpringerOpen.

Chicago Style (17th ed.) Citation

Rabab Mahmoud Ahmed, Nehal Kamal Rakha, Ahmed Yousry, and Amin Roshdy Soliman. Potential Impact of Sodium Glucose Co-transporter (SGLT2) Inhibitors on Cholesterol Fractions in Stage 3 Chronic Kidney Disease. SpringerOpen, 2024.

MLA (9th ed.) Citation

Rabab Mahmoud Ahmed, et al. Potential Impact of Sodium Glucose Co-transporter (SGLT2) Inhibitors on Cholesterol Fractions in Stage 3 Chronic Kidney Disease. SpringerOpen, 2024.